BIAFW
bioAffinity Technologies, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$0.30
+30.13%Next report
Analyst consensus
- Next report date
- Nov 18, 2026
- EPS estimate
- -$32
- Revenue estimate
- $1.9M
Latest reported
- Last report date
- Aug 7, 2026
- EPS actual
- -$0.64
- EPS estimate
- -$2.10
- Revenue actual
- $1.5M
- Revenue estimate
- $1.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +38.7%
- Revenue beats (12Q)
- 1
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 7, 2026 | -$2.10 | -$0.64 | Beat 69.52% | $1.5M |
| May 8, 2026 | -$2.40 | -$0.81 | Beat 66.25% | $1.4M |
| Nov 14, 2025 | -$2.70 | -$4.74 | Miss -75.44% | $1.4M |
| Aug 14, 2025 | -$3.00 | -$0.17 | Beat 94.36% | $1.3M |
| May 15, 2025 | -$0.16 | -$0.16 | Miss -2.26% | $1.9M |
| Jun 29, 2023 | — | -$0.00 | — | $19.7K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026